← Open Payments lookup

CAROLYN SUSCA: Open Payments

NPI 1205593951 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,967 in 106 payments from 15 companies in 2025. Trend: 2023 $1,714 · 2024 $3,569 · 2025 $1,967

Food & beverage: $1,967
CompanyPaymentsAmount
ABBVIE INC.24$315
Takeda Pharmaceuticals U.S.A., Inc.9$257
Janssen Biotech, Inc.17$237
Madrigal Pharmaceuticals7$236
Phathom Pharmaceuticals, Inc.8$207
Gilead Sciences, Inc.11$183
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$173
Lilly USA, LLC5$84
Celltrion USA Inc.3$65
Ipsen Biopharmaceuticals, Inc4$63

Products named: TREMFYA, REZDIFFRA, VOQUEZNA, XIFAXAN, ENTYVIO, RINVOQ, LINZESS, OMVOH.

Industry payments across TX — which companies pay providers there.